Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank38
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P38
Within normal range
vs 5Y Ago
-1.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-22.74%
2024618.01%
2023-37.08%
2022-58.40%
202183.33%
202021.17%
2019-48.60%
201862.90%
2017647.51%
2016-73.36%